Nanomedicine and Nanobiology
A section of Biomedicines (ISSN 2227-9059).
Section Information
This Section of Biomedicines aims to rapidly publish contributions on synthesis, bioavailability, and biodistribution of nanomedicines; delivery, pharmacodynamics, and pharmacokinetics of nanomedicines; imaging; diagnostics; improved therapeutics; innovative biomaterials; and interactions of nanomaterials with cells, tissues, and living organisms.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Advanced Research on Nanomaterials for Regenerative Medicine (Deadline: 30 April 2024)
- Engineered Nanomaterials for Diagnosis, Prevention and Therapy (Deadline: 30 April 2024)
- Nano-Medicine: Revolutionizing Therapeutics, Diagnostics, and Regeneration (Deadline: 30 April 2024)
- Nanobiomaterials with Antimicrobial and Anticancer Applications (Deadline: 30 April 2024)
- Advances in Nanomaterial-Based Drug Delivery Systems (Deadline: 31 May 2024)
- Preparation and Biomedical Application of Micro- and Nanocarriers of Active Substances (Deadline: 31 May 2024)
- Extracellular Vesicles and Lipid Nanoparticles in Cardiovascular Diseases (Deadline: 30 June 2024)
- Targeted Delivery of Nanoparticles via Blood Vessels (Deadline: 30 June 2024)
- Biosensors and Nanotechnology for Drug Discovery and Development (Deadline: 31 July 2024)
- Nanotechnology to Counter the Off-Target Toxicity of Therapeutics (Deadline: 30 September 2024)
- Nano-Based Drug Delivery and Drug Discovery (Deadline: 31 October 2024)
